Your browser doesn't support javascript.
loading
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities.
Walker, Meghan J; Blackmore, Kristina M; Chang, Amy; Lambert-Côté, Laurence; Turgeon, Annie; Antoniou, Antonis C; Bell, Kathleen A; Broeders, Mireille J M; Brooks, Jennifer D; Carver, Tim; Chiquette, Jocelyne; Després, Philippe; Easton, Douglas F; Eisen, Andrea; Eloy, Laurence; Evans, D Gareth; Fienberg, Samantha; Joly, Yann; Kim, Raymond H; Kim, Shana J; Knoppers, Bartha M; Lofters, Aisha K; Nabi, Hermann; Paquette, Jean-Sébastien; Pashayan, Nora; Sheppard, Amanda J; Stockley, Tracy L; Dorval, Michel; Simard, Jacques; Chiarelli, Anna M.
Affiliation
  • Walker MJ; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
  • Blackmore KM; Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Chang A; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
  • Lambert-Côté L; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
  • Turgeon A; CHU de Québec-Université Laval Research Center, Queébec City, QC G1V 4G2, Canada.
  • Antoniou AC; CHU de Québec-Université Laval Research Center, Queébec City, QC G1V 4G2, Canada.
  • Bell KA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge CB1 8RN, UK.
  • Broeders MJM; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
  • Brooks JD; Department for Health Evidence, Radboud University Medical Center, 6525EP Nijmegen, The Netherlands.
  • Carver T; Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Chiquette J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge CB1 8RN, UK.
  • Després P; CHU de Québec-Université Laval Research Center, Queébec City, QC G1V 4G2, Canada.
  • Easton DF; Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval, Québec City, QC G1V 0A6, Canada.
  • Eisen A; Department of Physics, Engineering Physics and Optics, Faculty of Science and Engineering, Université Laval, Quebec City, QC G1V 0A6, Canada.
  • Eloy L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge CB1 8RN, UK.
  • Evans DG; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
  • Fienberg S; Sunnybrook Health Science Center, Toronto, ON M4N 3M5, Canada.
  • Joly Y; Québec Cancer Program, Ministère de la Santé et des Services Sociaux, Quebec City, QC G1S 2M1, Canada.
  • Kim RH; Division of Evolution Infection and Genomic Sciences, The University of Manchester, Manchester M13 9PL, UK.
  • Kim SJ; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
  • Knoppers BM; Centre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.
  • Lofters AK; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
  • Nabi H; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.
  • Paquette JS; Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Pashayan N; Centre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.
  • Sheppard AJ; Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Stockley TL; Women's College Research Institute, Toronto, ON M5G 1N8, Canada.
  • Dorval M; CHU de Québec-Université Laval Research Center, Queébec City, QC G1V 4G2, Canada.
  • Simard J; Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada.
  • Chiarelli AM; Université Laval Cancer Research Center, Quebec City, QC G1R 3S3, Canada.
Cancers (Basel) ; 16(11)2024 May 31.
Article in En | MEDLINE | ID: mdl-38893236
ABSTRACT
Risk-stratified breast screening has been proposed as a strategy to overcome the limitations of age-based screening. A prospective cohort study was undertaken within the PERSPECTIVE I&I project, which will generate the first Canadian evidence on multifactorial breast cancer risk assessment in the population setting to inform the implementation of risk-stratified screening. Recruited females aged 40-69 unaffected by breast cancer, with a previous mammogram, underwent multifactorial breast cancer risk assessment. The adoption of multifactorial risk assessment, the effectiveness of methods for collecting risk factor information and the costs of risk assessment were examined. Associations between participant characteristics and study sites, as well as data collection methods, were assessed using logistic regression; all p-values are two-sided. Of the 4246 participants recruited, 88.4% completed a risk assessment, with 79.8%, 15.7% and 4.4% estimated at average, higher than average and high risk, respectively. The total per-participant cost for risk assessment was CAD 315. Participants who chose to provide risk factor information on paper/telephone (27.2%) vs. online were more likely to be older (p = 0.021), not born in Canada (p = 0.043), visible minorities (p = 0.01) and have a lower attained education (p < 0.0001) and perceived fair/poor health (p < 0.001). The 34.4% of participants requiring risk factor verification for missing/unusual values were more likely to be visible minorities (p = 0.009) and have a lower attained education (p ≤ 0.006). This study demonstrates the feasibility of risk assessment for risk-stratified screening at the population level. Implementation should incorporate an equity lens to ensure cancer-screening disparities are not widened.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2024 Document type: Article Affiliation country: Canada Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2024 Document type: Article Affiliation country: Canada Country of publication: Switzerland